Mesa Biotech is a healthcare test and data company that provides actionable information through trusted, PCR-based infectious disease testing—anytime, anywhere.* Our patented Accula™ System consists of a portable, palm-sized dock and assay-specific test cassettes. Wide access to polymerase chain reaction (PCR) based, Just in Time (JIT) testing enables instant mobility, appropriate treatments, and surveillance. Our mission is to democratize healthcare testing to positively impact human health through actionable data. *The Accula System has received FDA Emergency Use Authorization (EUA) for SARS-CoV-2 (the virus responsible for COVID-19) in vitro diagnostic testing. It is available now for use in patient care settings. The Accula Flu A/Flu B and the Accula RSV tests have obtained CE Mark in the EU and 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA).
View Top Employees from Mesa Biotech, Inc.Website | http://www.mesabiotech.com |
Revenue | $6 million |
Funding | $20.4 million |
Employees | 61 (61 on RocketReach) |
Founded | 2009 |
Address | 6190 Cornerstone Court E Suite 220, San Diego, California 92121, US |
Phone | (858) 800-4929 |
Technologies |
JavaScript,
HTML,
PHP
+83 more
(view full list)
|
Category | Biotechnology, Medical Equipment Manufacturing, Point of Care in vitro Diagnostic Testing, Pharmaceuticals, Science and Engineering, Infectious Diseases, Healthcare, Hospital, Medical Devices, Health Care, Medical Device |
Web Rank | 19 Million |
Keywords | mesa san diego pharma, mesa biotech |
SIC | 283, 28, 80 |
NAICS | 5417, 541, 54 |
Looking for a particular Mesa Biotech, Inc. employee's phone or email?
The Mesa Biotech, Inc. annual revenue was $6 million in 2023.
Pam Fettu is the Senior Director, Human Resources of Mesa Biotech, Inc..
61 people are employed at Mesa Biotech, Inc..
Mesa Biotech, Inc. is based in San Diego, California.
The NAICS codes for Mesa Biotech, Inc. are [5417, 541, 54].
The SIC codes for Mesa Biotech, Inc. are [283, 28, 80].